Analyst Ratings For NASDAQ:PRTO – Proteon Therapeutics (NASDAQ:PRTO)
Today, NASDAQ:PRTO – Proteon Therapeutics (NASDAQ:PRTO) stock received an upgrade by HC Wainwright from Neutral ➝ Buy with a price target of $3.00.
Some recent analyst ratings include
- 5/10/2018-HC Wainwright Upgrade from a “Neutral ➝ Buy” rating to a “” rating.
- 3/15/2018-Robert W. Baird Reiterated Rating of Outperform.
- 8/16/2017-Oppenheimer Reiterated Rating of Market Perform.
- 8/8/2017-Cowen Reiterated Rating of Hold.
- 12/14/2016-Raymond James Reiterated Rating of Strong-Buy ➝ Market Perform.
- 12/14/2016-JMP Securities was Downgraded by analysts at JMP Securities from a “Outperform ➝ Market Perform” rating to a “” rating.
Recent Insider Trading Activity For NASDAQ:PRTO – Proteon Therapeutics (NASDAQ:PRTO)
NASDAQ:PRTO – Proteon Therapeutics (NASDAQ:PRTO) has insider ownership of 45.70% and institutional ownership of 50.18%.
- On 12/15/2017 Steven Keith Burke, SVP, bought 12,000 with an average share price of $1.88 per share and the total transaction amounting to $22,560.00.
- On 11/30/2017 James E Flynn, Director, bought 110,557 with an average share price of $1.75 per share and the total transaction amounting to $193,474.75.
- On 11/14/2017 George Arthur Eldridge, CFO, bought 295 with an average share price of $1.69 per share and the total transaction amounting to $498.55.
- On 6/6/2016 George Arthur Eldridge, CFO, bought 4,000 with an average share price of $5.78 per share and the total transaction amounting to $23,120.00.
- On 12/1/2015 Timothy P. Noyes, CEO, sold 5,000 with an average share price of $14.97 per share and the total transaction amounting to $74,850.00.
- On 11/2/2015 Timothy P. Noyes, CEO, sold 5,000 with an average share price of $13.50 per share and the total transaction amounting to $67,500.00.
- On 10/1/2015 Timothy P. Noyes, CEO, sold 5,000 with an average share price of $13.33 per share and the total transaction amounting to $66,650.00.
Recent Trading Activity for NASDAQ:PRTO – Proteon Therapeutics (NASDAQ:PRTO)
Shares of NASDAQ:PRTO – Proteon Therapeutics closed the previous trading session at 2.22 up +0.12 5.85% with 9759 shares trading hands.